Beyond GOG-258 and PORTEC-3: a national cancer database analysis of adjuvant therapy for improved survival in high-risk endometrial cancer

被引：0
|
作者：
Lander, Megan [1 ]
Vargo, John [1 ]
Sukumvanich, Paniti [1 ]
机构：
[1] Univ Pittsburgh, Gynecol Oncol, Magee Womens Hosp, Med Ctr, Pittsburgh, PA USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.252
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EV133/#547
引用
收藏
页码：A154 / A154
页数：1
相关论文
共 50 条
  • [41] ADJUVANT CHEMOTHERAPY IS ASSOCIATED WITH IMPROVED LONG-TERM SURVIVAL IN STAGE II COLON CANCER IN THE ABSENCE OF HIGH-RISK FACTORS: A PROPENSITY MATCHED ANALYSIS UTILIZING THE NATIONAL CANCER DATABASE.
    Graham, A.
    Parascandola, S.
    Hota, S.
    Sparks, A.
    Obias, V.
    DISEASES OF THE COLON & RECTUM, 2020, 63 (06) : E154 - E154
  • [42] Hospital Database Validation of PORTEC3 Stage-Based Overall Survival Benefit for Chemoradiation Therapy in Endometrial Cancer
    Yu, E.
    DiPetrillo, T. A.
    Koffer, P. P.
    Miller, C. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E635 - E636
  • [43] Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial (vol 19, pg 295, 2018)
    de Boer, S. M.
    Powell, M. E.
    Mileshkin, L.
    LANCET ONCOLOGY, 2018, 19 (04): : E184 - E184
  • [44] Factors Affecting Receipt of Non-Definitive Therapy for High-Risk Prostate Cancer: A National Cancer Database Analysis
    Bagley, Alexander
    Anscher, Mitchell
    Choi, Seungtaek
    Frank, Steven J.
    Hoffman, Karen
    Kuban, Deborah
    McGuire, Sean
    Quynh-Nhu Nguyen
    Smith, Benjamin
    Smith, Grace
    Pezzi, Todd A.
    Chapin, Brian
    Aparicio, Ana
    Hess, Kenneth
    Tang, Chad
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (05): : E13 - E14
  • [45] Factors Affecting Receipt of Non-Definitive Therapy for High-Risk Prostate Cancer: A National Cancer Database Analysis
    Bagley, A.
    Anscher, M. S.
    Choi, S.
    Frank, S. J.
    Hoffman, K. E.
    Kuban, D. A.
    McGuire, S. E.
    Nguyen, Q. N.
    Smith, B. D.
    Smith, G. L.
    Chapin, B.
    Aparicio, A.
    Pezzi, T. A.
    Hess, K.
    Tang, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E452 - E452
  • [46] Disease free survival as a predictor of overall survival in patients with high-risk endometrial cancer receiving adjuvant chemotherapy
    Kponee-Shovein, Kale
    Prabhu, Vimalanand S.
    Song, Yan
    Chen, Lei
    Cheng, Mu
    Li, Yeran
    Sun, Yezhou
    Hilts, Annalise
    Hua, Qi
    Lichfield, Jasmine
    Duska, Linda
    CLINICAL CANCER RESEARCH, 2024, 30 (05)
  • [47] Minimally invasive surgery is associated with improved survival in patients with Type II endometrial cancer: An analysis of the national cancer database
    Zhang, Qi
    Silver, Michael
    Chen, Yi-Ju
    Wolf, Jennifer
    Hayek, Judy
    Palileo, Albert
    Alagkiozidis, Ioannis
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S88 - S88
  • [48] PORTEC-3-Studie für Endometriumkarzinome mit hohem Risiko: Auswirkungen der molekularen Klassifizierung auf die Prognose und den Nutzen einer adjuvanten TherapieThe PORTEC-3 trial for high-risk endometrial cancer: impact of molecular classification on prognosis and benefit from adjuvant therapy
    Simone Marnitz
    Birgid Schömig-Markiefka
    Strahlentherapie und Onkologie, 2021, 197 (3) : 266 - 268
  • [49] The addition of adjuvant chemotherapy to radiation in high-risk endometrial cancer: Survival outcomes and patterns of care.
    Boothe, Dustin
    Williams, Ned
    Odei, Bismarck
    Poppe, Matt
    Werner, Theresa Louise
    Suneja, Gita
    Gaffney, David K.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] Improved overall survival with adjuvant radiotherapy for high-intermediate and high risk Stage I endometrial cancer
    Harkenrider, Matthew M.
    Adams, William
    Block, Alec
    Kliethermes, Stephanie
    Small, William, Jr.
    Grover, Surbhi
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 (03) : 452 - 457
12345